(Reuters) - Pfizer Inc (PFE.N) plans to complete a review this year of whether it should divest any of its businesses to maximize their value, a top executive at the drugmaker said on Thursday.
(Reuters) - Pfizer Inc (PFE.N) plans to complete a review this year of whether it should divest any of its businesses to maximize their value, a top executive at the drugmaker said on Thursday.